Recent Updates
Recently added Catalysts
NUS

Nu Skin Enterprises Reports Second Quarter Financial Results

Key Takeaway: Nu Skin Enterprises Reports Second Quarter Financial Results PROVO, Utah - Aug. 4, 2022 - Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2022 results. Q2 2022 vs. Prior-year Quarter Revenue: $560.6 million; (20)% (5)% FX impact or $(34.6) million Earni

Full Press Release Details

Nu Skin Enterprises Reports Second Quarter Financial Results
PROVO, Utah - Aug. 4, 2022 - Nu Skin Enterprises,
Inc. (NYSE: NUS) today announced second quarter 2022 results.
Q2 2022 vs. Prior-year Quarter
Revenue: $560.6 million; (20)% (5)% FX impact or $(34.6) million
Earnings Per Share (EPS): $0.67 or $0.77 excluding charges associated with our Q4 2021 exit from Grow Tech, compared to $1.15 in Q2 2021
Customers: 1,380,615; (6)%
Paid Affiliates: 242,133; (16)%
Sales Leaders: 50,085; (24)%
"As previously announced, our second quarter results were impacted by extended COVID-related factors in Mainland China, distractions in EMEA related to the ongoing
conflict, weaker global economic conditions impacting emerging markets and the record strength of the U.S. dollar," said Ryan Napierski, Nu Skin president and CEO. "Despite these challenges, we delivered our ninth consecutive quarter of growth in
the U.S. on the strength of new product launches and our social commerce model. Additionally, we drove year-over-year growth in our Southeast Asia/Pacific and Hong Kong/Taiwan segments due to the successful launch of ageLOC Meta and early social
"Looking toward the balance of the year, we remain focused on Nu Vision 2025, including:
"Given the current landscape, we are taking aggressive measures to re-align our capabilities and resources with a focus on delivering Nu Vision 2025, which will
result in a restructuring event in the second half and reduced operating expenses going forward. While we anticipate macro factors will continue to weigh on the business in the short-term, we remain confident in the direction and potential of
Q2 2022 Year-over-year Operating Results
Revenue: $560.6 million compared to $704.1 million (5)% FX impact
Gross Margin: 73.6% compared to 75.6% Impacted by product mix and foreign currency exchange Nu Skin business was 77.0% compared to 78.3%
Selling Expenses: 39.1% compared to 39.9% Nu Skin business was 42.0% compared to 42.8%
G&A Expenses: 25.3% compared to 23.6%
Operating Margin: 9.2% compared to 12.1%
Other Income / (Expense): $(8.6) million or $(2.9) million excluding charges associated with our Q4 2021 exit from Grow Tech, compared to $(4.0) million
Income Tax Rate: 20.2% compared to 27.1%
EPS: $0.67 or $0.77 excluding charges associated with our Q4 2021 exit from Grow Tech, compared to $1.15 in Q2 2021
Dividend Payments: $19.4 million
Stock Repurchases: $10.0 million $225.4 million remaining in authorization
Q3 and Full-year 2022 Outlook
Q3 2022 Revenue: $550 to $590 million; (13) to (8)% Approximately (6)% FX impact
Q3 2022 EPS: $0.04 to $0.22 or $0.70 to $0.85 non-GAAP
2022 Revenue: $2.33 to $2.41 billion; (14) to (11)% Approximately (5)% FX impact
2022 EPS: $2.46 to $2.76 or $3.30 to $3.60 non-GAAP
"In light of the heightened global uncertainties and their impact on our business, we are adjusting our annual guidance," added Mark Lawrence,
chief financial officer. "Our 2022 revenue guidance is now expected to be $2.33 to $2.41 billion, with an approximate 5 percent foreign currency headwind. We anticipate reported EPS of $2.46 to $2.76 or $3.30 to $3.60 excluding the Q2 charges
associated with our Q4 2021 exit from Grow Tech, as well as second half restructuring and impairment charges of $35 to $45 million associated with the strategic reallocation of our capabilities and resources toward Nu Vision 2025. We believe
these actions will benefit the balance of 2022 and provide approximately $100 million in cost savings in 2023. For the third quarter, we project revenue of $550 to $590 million, assuming a negative foreign currency impact of approximately 6
percent, with reported earnings per share of $0.04 to $0.22 or $0.70 to $0.85 when excluding the third-quarter charge of approximately $30 million of the $35 to $45 million estimate."
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the
webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available on the same page through Aug. 18, 2022.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NYSE: NUS) is a global integrated beauty and wellness company, powered by a dynamic affiliate opportunity platform. The
company helps people look, feel and live their best with products that combine the best of science, technology and nature. Backed by more than 35 years of scientific research, Nu Skin develops innovative products including Nu Skin personal care,
Pharmanex nutrition and the ageLOC anti-aging brand which includes an award-winning line of beauty device systems. Nu Skin operates in approximately 50 markets worldwide in the Americas, Asia, Europe, Africa and the Pacific. Rhyz Inc. is the
company's strategic investment arm that includes a collection of technology and manufacturing companies to support growth in the core Nu Skin business. Nu Skin is committed to sustainability, including global initiatives such as transitioning to
reduced and sustainable packaging for all products by 2030. The Nu Skin Force for Good Foundation also strives to improve children's health, education and economic circumstances throughout the world. For more information, visit nuskin.com.
Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the
company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's
expectations regarding the company's performance, growth, shareholder value, strategies, vision, transformation, initiatives, product pipeline and product introductions, digital and social-commerce tools and initiatives, customers, sales leaders,
affiliates, and operational improvements; projections regarding revenue, expenses, operating income, earnings per share, foreign currency fluctuations, uses of cash and other financial items; statements of belief; and statements of assumptions
underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "anticipate," "project," "outlook," "guidance," "remain," "become," "plan," "potential," "expand," "will,"
"would," "could," "may," "might," the negative of these words and other similar words.
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:
The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of
associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided, and the company
assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.
Non-GAAP Financial Measures:
Constant-currency revenue change is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company's performance. It is calculated by
translating the current period's revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period's revenue. The company believes that constant-currency revenue
change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company's revenue from period to period.
Earnings per share and other income (expense), each excluding restructuring and impairment charges and/or charges associated with our Grow Tech
exit, also are non-GAAP financial measures. Restructuring and impairment charges and charges associated with our Grow Tech exit are not part of the ongoing operations of our underlying business. The company believes that these non-GAAP financial
measures are useful to investors, lenders and analysts because removing the impact of restructuring and impairment charges and charges associated with our Grow Tech exit facilitates period-to-period comparisons of the company's performance. Please
see the reconciliations of these items to our earnings per share and other income (expense) calculated under GAAP, below.
The following table sets forth revenue for the three-month periods ended June 30, 2022 and 2021 for each of our reportable segments (U.S. dollars in thousands):
Three Months Ended June 30, Change Constant- Currency Change
2022 2021
Nu Skin
Americas $ 124,445 $ 138,512 (10 )% (9 )%
Mainland China 86,808 154,182 (44 )% (42 )%
Southeast Asia/Pacific 94,067 83,968 12 % 16 %
South Korea 69,308 88,604 (22 )% (12 )%
Japan 55,952 68,020 (18 )% (3 )%
EMEA 50,871 83,115 (39 )% (31 )%
Hong Kong/Taiwan 39,327 38,529 2 % 6 %
Nu Skin other 1,318 947 39 % 39 %
Total Nu Skin 522,096 655,877 (20 )% (15 )%
Rhyz Investments
Manufacturing 38,229 48,140 (21 )% (21 )%
Rhyz other 290 38 663 % 663 %
Total Rhyz Investments 38,519 48,178 (20 )% (20 )%
Total $ 560,615 $ 704,055 (20 )% (15 )%
The following table sets forth revenue for the six-month periods ended June 30, 2022 and 2021 for each of our reportable segments (U.S. dollars in thousands):
Six Months Ended June 30, Change Constant- Currency Change
2022 2021
Nu Skin
Americas $ 248,025 $ 272,273 (9 )% (8 )%
Mainland China 211,303 303,775 (30 )% (31 )%
Southeast Asia/Pacific 184,303 167,257 10 % 14 %
South Korea 141,441 169,735 (17 )% (8 )%
Japan 117,743 137,884 (15 )% (3 )%
EMEA 103,839 159,295 (35 )% (28 )%
Hong Kong/Taiwan 77,821 74,874 4 % 6 %
Nu Skin other 1,938 1,825 6 % 6 %
Total Nu Skin 1,086,413 1,286,918 (16 )% (12 )%
Rhyz Investments
Manufacturing 78,570 94,125 (17 )% (17 )%
Rhyz other 531 38 1,297 % 1,297 %
Total Rhyz Investments 79,101 94,163 (16 )% (16 )%
Total $ 1,165,514 $ 1,381,081 (16 )% (12 )%
The following table provides information concerning the number of Customers, Paid Affiliates and Sales Leaders in our core Nu Skin business for the three-month periods
ended June 30, 2022 and 2021:
Three Months Ended June 30, Change
Customers 2022 2021
Americas 302,849 368,052 (18 )%
Mainland China $ 392,268 328,526 19 %
Southeast Asia/Pacific 152,775 165,221 (8 )%
South Korea 135,290 153,282 (12 )%
Japan 122,643 125,734 (2 )%
EMEA 205,379 261,881 (22 )%
Hong Kong/Taiwan 69,411 64,861 7 %
Total 1,380,615 1,467,557 (6 )%
Three Months Ended June 30, Change
Paid Affiliates 2022 2021
Americas 44,523 53,492 (17 )%
Mainland China $ 19,257 39,889 (52 )%
Southeast Asia/Pacific 41,512 44,734 (7 )%
South Korea 48,605 52,680 (8 )%
Japan 38,269 38,623 (1 )%
EMEA 32,323 42,682 (24 )%
Hong Kong/Taiwan 17,644 17,815 (1 )%
Total 242,133 289,915 (16 )%
Three Months Ended June 30, Change
Sales Leaders 2022 2021
Americas 9,320 11,752 (21 )%
Mainland China $ 11,458 20,946 (45 )%
Southeast Asia/Pacific 8,407 8,190 3 %
South Korea 6,557 7,701 (15 )%
Japan 6,097 6,057 1 %
EMEA 5,192 8,002 (35 )%
Hong Kong/Taiwan 3,054 3,446 (11 )%
Total 50,085 66,094 (24 )%
"Customers" are persons who have purchased
directly from the Company during the three months ended as of the date indicated. Our Customer numbers include members of our sales force who made such a purchase, including Paid Affiliates and those who qualify as Sales Leaders, but they do not
include consumers who purchase products directly from members of our sales force.
"Paid Affiliates" are any Brand Affiliates, as well as sales employees and independent marketers in
Mainland China, who earned sales compensation during the three-month period. In all of our markets besides Mainland China, we refer to members of our independent sales force as "Brand Affiliates" because their primary role is to promote our brand
and products through their personal social networks.
"Sales Leaders" are the three-month average of
our monthly Brand Affiliates, as well as sales employees and independent marketers in Mainland China, who had achieved certain qualification requirements as of the end of each month of the quarter.
NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
(U.S. dollars in thousands, except per share amounts)
Three Months Ended June 30, Six Months Ended June 30,
2022 2021 2022 2021
Revenue $ 560,615 $ 704,055 $ 1,165,514 $ 1,381,081
Cost of sales 148,100 171,975 309,599 342,541
Gross profit 412,515 532,080 855,915 1,038,540
Operating expenses:
Selling expenses 219,426 280,589 462,125 556,554
General and administrative expenses 141,562 166,115 290,118 333,697
Total operating expenses 360,988 446,704 752,243 890,251
Operating income 51,527 85,376 103,672 148,289
Other income (expense), net (8,640 ) (4,012 ) (10,093 ) (2,430 )
Income before provision for income taxes 42,887 81,364 93,579 145,859
Provision for income taxes 8,650 22,026 20,626 39,091
Net income $ 34,237 $ 59,338 $ 72,953 $ 106,768
Net income per share:
Basic $ 0.68 $ 1.18 $ 1.45 $ 2.12
Diluted $ 0.67 $ 1.15 $ 1.43 $ 2.06
Weighted-average common shares outstanding (000s):
Basic 50,368 50,115 50,181 50,409
Diluted 50,960 51,557 50,959 51,850
NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(U.S. dollars in thousands)
June 30, 2022 December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents $ 363,923 $ 339,593
Current investments 17,877 15,221
Accounts receivable, net 43,694 41,299
Inventories, net 354,211 399,931
Prepaid expenses and other 103,188 76,906
Total current assets 882,893 872,950
Property and equipment, net 443,036 453,674
Operating lease right-of-use assets 118,413 120,973
Goodwill 206,432 206,432
Other intangible assets, net 72,665 76,991
Other assets 177,462 175,460
Total assets $ 1,900,901 $ 1,906,480
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 55,013 $ 49,993
Accrued expenses 289,130 372,201
Current portion of long-term debt 40,000 107,500
Total current liabilities 384,143 529,694
Operating lease liabilities 90,156 88,759
Long-term debt 387,179 268,781
Other liabilities 98,388 106,474
Total liabilities 959,866 993,708
Commitments and contingencies
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued 91 91
Additional paid-in capital 606,349 601,703
Treasury stock, at cost - 39.9 million and 40.7 million shares (1,520,769 ) (1,526,860 )
Accumulated other comprehensive loss (90,638 ) (73,896 )
Retained earnings 1,946,002 1,911,734
Total stockholders' equity 941,035 912,772
Total liabilities and stockholders' equity $ 1,900,901 $ 1,906,480
NU SKIN ENTERPRISES, INC.
Reconciliation of Earnings Per Share Excluding Charges Associated with Our Q4 2021
Exit from Grow Tech to GAAP Earnings Per Share
(in thousands, except per share amounts)
Three Months Ended June 30, 2022
Net income $ 34,237
Impact of charges associated with our Q4 2021 exit from Grow Tech:
Unrealized investment loss 5,711
Income tax impact (459 )
Adjusted net income $ 39,489
Diluted earnings per share $ 0.67
Diluted earnings per share, excluding charges associated with our Q4 2021 exit from Grow Tech $ 0.77
Weighted-average common shares outstanding (000s): 50,960
NU SKIN ENTERPRISES, INC.
Reconciliation of Other Income (Expense), Net Excluding Charges Associated with Our Q4 2021 Exit from Grow Tech to GAAP Other Income (Expense), Net
Three Months Ended June 30, 2022
Other income (expense), net $ (8,640 )
Impact of charges associated with our Q4 2021 exit from Grow Tech:
Unrealized investment loss 5,711
Adjusted Other income (expense), net $ (2,929 )
NU SKIN ENTERPRISES, INC.
Reconciliation of Earnings Per Share Excluding Certain Charges to GAAP Earnings Per Share
Three Months Ended September 30, 2022 Year Ended December 31, 2022
Low End High End Low End High End
Earnings per share $ 0.04 $ 0.22 $ 2.46 $ 2.76
Impact of charges associated with our second half restructuring and impairment charges:
Restructuring and Impairment 0.59 0.59 0.88 0.88
Income tax impact 0.07 0.04 (0.13 ) (0.13 )
Impact of charges associated with our Q4 2021 exit from Grow Tech:
Unrealized investment loss - - 0.11 0.11
Income tax impact - - (0.02 ) (0.02 )
Adjusted Earnings per share $ 0.70 $ 0.85 $ 3.30 $ 3.60
Media: media@nuskin.com, (801) 345-6397
Investors: investorrelations@nuskin.com, (801) 345-3577
Last updated: Aug 4, 2022